Covered recipient · General Payments record
MARIA D ORTIZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$661.28
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.87 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $50.21 | 2 |
| QOL Medical, LLC | $44.63 | 2 |
| Celltrion USA Inc. | $36.94 | 2 |
| Novo Nordisk AS | $24.63 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celltrion USA Inc. | $16.18 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075865763 | CMS |
| Celltrion USA Inc. | $20.76 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075865765 | CMS |
| Lilly USA, LLC | $32.08 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135834571 | CMS |
| Lilly USA, LLC | $18.13 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135803822 | CMS |
| Novo Nordisk Inc | $24.63 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100451988 | CMS |
| QOL Medical, LLC | $22.60 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147743606 | CMS |
| QOL Medical, LLC | $22.03 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147743608 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.53 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153630393 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.93 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137803148 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.